Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: skinowski who wrote (755283)	1/17/2022 2:42:12 PM
From: D. Long	Read Replies (1) \| Respond to of 793818

Very interesting. Who would have thought melatonin would have any significant effects?

To: skinowski who wrote (755283)	1/17/2022 2:46:40 PM
From: i-node	1 Recommendation Recommended By skinowski Respond to of 793818

I started taking melatonin a few years ago when I determined I needed to wean off of, or at least reduce my intake of Ambien. I was able to get down to 5mg of Ambien by taking 10mg of melatonin. How lucky when you stumble into something that helps with Covid...

To: skinowski who wrote (755283)	1/17/2022 2:52:12 PM
From: DMaA	Read Replies (2) \| Respond to of 793818

I haven't been able to find zinc in any store for a while now.

To: skinowski who wrote (755283)	1/17/2022 3:48:10 PM
From: MulhollandDrive	3 Recommendations Recommended By Bill isopatch skinowski Respond to of 793818

one of the contributors on a health forum i subscribe to has published numerous articles as it relates to the benefits of melatonin which has good melatonin, strong anti-inflammatory, anti-oxidative molecule <snip> Abstract This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. Notably, melatonin has a high safety profile. There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients. Additional experiments and clinical studies are required to confirm this speculation.